×
Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ambrx Biopharma Inc. Financial Statements 2019-2025 | AMAM

Annual Data | Millions of US $ except per share data
2022-12-31
2021-12-31
2020-12-31
2019-12-31
$7.402
$7.455
$13.671
$10.311
Cost Of Goods Sold
-
-
-
-
$7.402
$7.455
$13.671
$10.311
$53.307
$54.295
$20.433
$26.383
$20.836
$17.071
$6.353
$6.4
Other Operating Income Or Expenses
-
-
-
-
Operating Expenses
-
-
-
-
$-66.741
$-63.911
$-13.115
$-22.472
Total Non-Operating Income/Expense
$-9.318
$-4.376
$-4.723
$0.157
$-76.059
$-68.287
$-17.838
$-22.315
Income Taxes
$1.937
$0.001
$0.001
$-0.002
$-77.996
$-68.288
$-17.839
$-22.313
Other Income
-
-
-
-
$-77.996
$-68.288
$-17.839
$-22.313
Income From Discontinued Operations
-
-
-
-
$-77.996
$-68.079
$-16.543
$-20.062
EBITDA
$-65.448
$-61.757
$-11.172
$-20.419
EBIT
$-66.741
$-63.911
$-13.115
$-22.472
$-2.02
$-3.33
$-0.98
$-1.05
$-2.02
$-3.33
$-0.98
$-1.05